KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Cme (CME) over the last 17 years, with Q3 2025 value amounting to -$25.5 million.

  • Cme's Change in Receivables fell 18585.86% to -$25.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.1 million, marking a year-over-year decrease of 8036.21%. This contributed to the annual value of $39.4 million for FY2024, which is 2349.51% down from last year.
  • As of Q3 2025, Cme's Change in Receivables stood at -$25.5 million, which was down 18585.86% from -$101.4 million recorded in Q2 2025.
  • In the past 5 years, Cme's Change in Receivables registered a high of $241.2 million during Q1 2023, and its lowest value of -$125.5 million during Q2 2023.
  • For the 5-year period, Cme's Change in Receivables averaged around $13.6 million, with its median value being -$25.5 million (2025).
  • In the last 5 years, Cme's Change in Receivables tumbled by 670000.0% in 2023 and then skyrocketed by 17279.41% in 2024.
  • Over the past 5 years, Cme's Change in Receivables (Quarter) stood at -$36.1 million in 2021, then tumbled by 166.76% to -$96.3 million in 2022, then skyrocketed by 75.7% to -$23.4 million in 2023, then plummeted by 138.46% to -$55.8 million in 2024, then surged by 54.3% to -$25.5 million in 2025.
  • Its last three reported values are -$25.5 million in Q3 2025, -$101.4 million for Q2 2025, and $196.8 million during Q1 2025.